LGALS9 and COVID-19: We suggested that Gal-9 could be cleaved as soon as its release into blood in severe conditions but not the recovery phase by TCZ treatment, implying that inhibition of the IL-6 signaling cascade in severe COVID-19 may enhance the subsidence of Gal-9 proteolysis.